In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Latest
ThermaCare expands to topical pain relief with new Heat + Lidocaine Line
Therapeutic heat enhances comfort while helping lidocaine penetrate deeply to numb pain at the source.
The innovators behind Women’s Wellness: The Next Revolution
The sponsors of Women’s Wellness: The Next Revolution are helping redefine how brands meet the evolving needs of today’s wellness consumer.
Dollar General marks nearly two decades of Habitat for Humanity partnership
Dollar General celebrated 19 years of partnership with Habitat for Humanity of Greater Nashville as more than 80 employees volunteered 550 hours helping build homes for families in South Nashville.
Lilly strengthens neuroscience portfolio with Centessa acquisition
Eli Lilly completed acquiring Centessa Pharmaceuticals, adding orexin receptor 2 agonists for narcolepsy and sleep disorders as it expands its neuroscience pipeline.